BIRC5 and ovarian cancer: In turn, studies by Cohen [21], Ferrandina [22], Liguang [37] and Athanassiadou [24] and colleagues showed that the expression of survivin in ovarian cancer was closely related to the FIGO status, tumour grade and histological type, but showed no effect on the age of the patient.